BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23672482)

  • 1. Differential morphology and homogeneity of tissue-engineered cartilage in hydrodynamic cultivation with transient exposure to insulin-like growth factor-1 and transforming growth factor-β1.
    Yang YH; Barabino GA
    Tissue Eng Part A; 2013 Nov; 19(21-22):2349-60. PubMed ID: 23672482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wavy-walled bioreactor supports increased cell proliferation and matrix deposition in engineered cartilage constructs.
    Bueno EM; Bilgen B; Barabino GA
    Tissue Eng; 2005; 11(11-12):1699-709. PubMed ID: 16411815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirement for serum in medium supplemented with insulin-transferrin-selenium for hydrodynamic cultivation of engineered cartilage.
    Yang YH; Barabino GA
    Tissue Eng Part A; 2011 Aug; 17(15-16):2025-35. PubMed ID: 21457088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient exposure to transforming growth factor beta 3 improves the mechanical properties of mesenchymal stem cell-laden cartilage constructs in a density-dependent manner.
    Huang AH; Stein A; Tuan RS; Mauck RL
    Tissue Eng Part A; 2009 Nov; 15(11):3461-72. PubMed ID: 19432533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentric cylinder bioreactor for production of tissue engineered cartilage: effect of seeding density and hydrodynamic loading on construct development.
    Saini S; Wick TM
    Biotechnol Prog; 2003; 19(2):510-21. PubMed ID: 12675595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type I collagen-based fibrous capsule enhances integration of tissue-engineered cartilage with native articular cartilage.
    Yang YH; Ard MB; Halper JT; Barabino GA
    Ann Biomed Eng; 2014 Apr; 42(4):716-26. PubMed ID: 24362632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient exposure to transforming growth factor beta 3 under serum-free conditions enhances the biomechanical and biochemical maturation of tissue-engineered cartilage.
    Byers BA; Mauck RL; Chiang IE; Tuan RS
    Tissue Eng Part A; 2008 Nov; 14(11):1821-34. PubMed ID: 18611145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneous engineered cartilage growth results from gradients of media-supplemented active TGF-β and is ameliorated by the alternative supplementation of latent TGF-β.
    Albro MB; Nims RJ; Durney KM; Cigan AD; Shim JJ; Vunjak-Novakovic G; Hung CT; Ateshian GA
    Biomaterials; 2016 Jan; 77():173-185. PubMed ID: 26599624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomaterial effects in articular cartilage tissue engineering using polyglycolic acid, a novel marine origin biomaterial, IGF-I, and TGF-beta 1.
    DiCarlo BB; Hu JC; Gross T; Vago R; Athanasiou KA
    Proc Inst Mech Eng H; 2009 Jan; 223(1):63-73. PubMed ID: 19239068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-nanofiber-based cartilage tissue engineering using improved cell seeding, growth factor, and bioreactor technologies.
    Li WJ; Jiang YJ; Tuan RS
    Tissue Eng Part A; 2008 May; 14(5):639-48. PubMed ID: 18419231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous versus exogenous growth factor regulation of articular chondrocytes.
    Shi S; Chan AG; Mercer S; Eckert GJ; Trippel SB
    J Orthop Res; 2014 Jan; 32(1):54-60. PubMed ID: 24105960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of proteoglycan 4 metabolism in cartilage by IL-1alpha, IGF-I, and TGF-beta1.
    Schmidt TA; Gastelum NS; Han EH; Nugent-Derfus GE; Schumacher BL; Sah RL
    Osteoarthritis Cartilage; 2008 Jan; 16(1):90-7. PubMed ID: 17596975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth factors for sequential cellular de- and re-differentiation in tissue engineering.
    Pei M; Seidel J; Vunjak-Novakovic G; Freed LE
    Biochem Biophys Res Commun; 2002 May; 294(1):149-54. PubMed ID: 12054755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of TGF-beta1 and IGF-I on the biomechanics and cytoskeleton of single chondrocytes.
    Leipzig ND; Eleswarapu SV; Athanasiou KA
    Osteoarthritis Cartilage; 2006 Dec; 14(12):1227-36. PubMed ID: 16824771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anabolic actions of IGF-I and TGF-beta1 on Interleukin-1beta-treated human articular chondrocytes: evaluation in two and three dimensional cultures.
    Seifarth C; Csaki C; Shakibaei M
    Histol Histopathol; 2009 Oct; 24(10):1245-62. PubMed ID: 19688693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of growth factors on tissue-engineered cartilage.
    Blunk T; Sieminski AL; Gooch KJ; Courter DL; Hollander AP; Nahir AM; Langer R; Vunjak-Novakovic G; Freed LE
    Tissue Eng; 2002 Feb; 8(1):73-84. PubMed ID: 11886656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of immature articular cartilage compressive moduli and Poisson's ratios by in vitro stimulation with IGF-1 and TGF-beta1.
    Williams GM; Dills KJ; Flores CR; Stender ME; Stewart KM; Nelson LM; Chen AC; Masuda K; Hazelwood SJ; Klisch SM; Sah RL
    J Biomech; 2010 Sep; 43(13):2501-7. PubMed ID: 20570267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-β1 and IGF-1 influence the re-differentiation capacity of human chondrocytes in 3D pellet cultures in relation to different oxygen concentrations.
    Jonitz A; Lochner K; Tischer T; Hansmann D; Bader R
    Int J Mol Med; 2012 Sep; 30(3):666-72. PubMed ID: 22736084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms underlying the synergistic enhancement of self-assembled neocartilage treated with chondroitinase-ABC and TGF-β1.
    Responte DJ; Arzi B; Natoli RM; Hu JC; Athanasiou KA
    Biomaterials; 2012 Apr; 33(11):3187-94. PubMed ID: 22284584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cartilage constructs engineered from chondrocytes overexpressing IGF-I improve the repair of osteochondral defects in a rabbit model.
    Madry H; Kaul G; Zurakowski D; Vunjak-Novakovic G; Cucchiarini M
    Eur Cell Mater; 2013 Apr; 25():229-47. PubMed ID: 23588785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.